GET MORE AI-GENERATED SIGNALS: September 19, 2024, 20:16 pm ET, BY Jeff W.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...

(Reuters) - The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on ...

The European stock markets closed lower in Wednesday trading as The Stoxx Europe 600 was down 0.49%, the Swiss Market Index declined 0.50%, France's CAC dropped 0.57%, the FTSE in London fell 0.68%, ...

GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...

(Reuters) - British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer. GSK does not admit to any ...

Earlier this year, Nucala rolled out the Let’s Get to It campaign, which opts for an “unapologetically candid” tone, ...

Teos Therapeutics' belrestotug shows promising response rates in lung cancer trials. Read more to see why I'm bullish on ITOS ...

Early data from GSK Plc and iTeos Therapeutics’ mid-stage trial of a lung cancer medicine looks set to renew cautious ...

Elsewhere in the small-cap space, Chariot, a Morocco-focused oil and gas group, appeared to deflate investor expectations ...

A major player of,Healthcare sector,, GSK PLC (,NYSE:GSK,) has received Breakthrough Therapy Designation (BTD) in China for ...

Industry observers share that while KBC remains a high-impact show with Amitabh Bachchan's strong mass appeal, some advertisers may wait for more data before getting on board ...

DeepWell Digital Therapeutics received 510 (k) clearance from the FDA on its biofeedback software development kit for use in ...